Heterologous anti-lymphocytic antiserum is a potent immunosuppressive agent capable of prolonging the survival of allografts in experimental animals (1, 2, 4, 5, 7) and man (3). The mechanism of action of the antiserum, however, remains obscure. In particular, experimental evidence has varied concerning the significance of lymphopenia during the period of immunosuppression (4-8).
ANTI-LYM~PHOCYTIC S E R~ A N D S M A L L LYMIPHOCYTES
Antisarum.--Rabbit anti-rat thymocyte serum (RARTS) was prepared by the method described by Levey and Medawar (5) . Each of a group of eight rabbits was injected intravenously with 1 billion thymocytes from weanling Lewis rats, and 14 days later each rabbit received a second similar intravenous injection. The rabbits were exsanguinated 7 days after their second injection, their sera pooled and then decomplemented by heating at 56°C for 30 rain. The serum was absorbed for 1 hr at room temperature against Lewis red blood ceils, which had been washed twice in Ringer's solution, and was then filtered through a Millipore filter and kept frozen at --20°C until used. Normal rabbit serum (NRS) was obtained from unlmmunized rabbits and handled in the same fashion. The dose of RARTS or NRS employed was 1.5 ml/100 g body weight and was given as three subcutaneous injections over a 1 rain period into the shaved back of each etheranesthetized rat. It caused no detectable systemic toxicity or anemia.
The potency of the antiserum was qualitatively demonstrated by its ability to prolong the survival of (Lewis X BN) F1 grafts on Lewis hosts as follows: Six Lewis rats were grafted with (Lewis × BN)F1 skin. Two of them were given 1.5 ml/100 g body weight RARTS on days -4-2 and A-S; two received NRS in the same dose schedule; and two were left untreated. The NRStreated and untreated rats began rejecting their skin grafts between the 7th and 9th day, and rejection was complete in all cases by day -4-12. The RARTS-treated rats had normal appearing grafts until days + 2 0 and + 2 4 when graft rejection was first noted. Graft rejections once underway proceeded in a normal fashion.
Thorac~ Duot Lymplwcytes.--Lymphocytes were obtained by cannulating the thoracic ducts of male Lewis rats, weighing 200-250 g, according to the method of Wilson (13) . In each instance, free flow of thoracic duct lymph was obtained with no evidence of clot formation or active bleeding. The lymph was collected in 20-100 ml of heparinized Ringer's solution maintained at 4°C. The collection period for each sample, unless otherwise noted, was approximately 24 hr. The cells were concentrated by eentrifugation and washed once in Ringer's solution. An aliquot of the washed cells was resuspended in 0.0S per cent trypan blue and allowed to stand for 3-5 rain prior to counting; those cells not stained with trypan blue were considered viable. Giemsa smears were also prepared from most 24 hr collections for differential counts.
Graft vs. Host Assay.--The unpooled thoracic duct lymphocytes, collected within 48 hr after cannulation of the various donors, were injected in doses ranging from 5 to 40 million ceils into the orbital branch of the anterior facial vein of (Lewis X BN)FI rats less than 24 hr of age. The injections were usually well tolerated. Litters always included two noninjected controls. Beginning at 10 days of age, the FI hybrid animals were weighed thrice weekly and inspected for signs of skin changes pathognomonlc of graft vs. host (GVH) reactions (14) . The date of death of each animal undergoing a GVH reaction was noted. Death was ascribed to a GVH reaction only if the animal showed characteristic thickening of the skin, followed by a marked dermatitis and failure to gain weight at a normal rate. Animals with these signs, surviving more than 40 days, were classified as having nonfatal GVH disease. Preliminary experiments revealed that injected rats showing no signs of GVH reactions at 40 days always continued to grow normally. Because these differences in response were clear cut, no further gradation of GVH reactions was necessary.
Fluorescent Antibody Studies.--Preliminary in vitro studies were done to determine the approximate sensitivity of indirect staining with fluorescent antibody. 5 million washed thoracic duct lymphocytes were resuspended in 0.2 ml Ringer's solution and incubated for 30 rain at 37°C with 0.1 ml of RARTS ranging in concentrations from 1:10 to 1:2560. The cells were then washed twice and incubated at room temperature for 20 rain with 0.1 ml of a 1:5 dilution of fluorescein-conjugated goat-anti-rabbit gamma globulin (kindly supplied by Dr. R. Asofsky). Mter two more washings, aliquots of the cells were examined by fluorescent microscopy (X 950). Fluorescence was seen as a ring around the cell wall with no detectable intracellular localization. There was uniform staining of all cells incubated with a sufficient concentration of PARTS, and the staining decreased as the serum was diluted. In two separate experiments, the highest dilutions of antiserum that gave definitely positive recations were 320 and 640 respectively. Lymphocytes incubated with normal rabbit serum did not stain. The method was there/ore adopted to detect the presence of antibody on the surfaces of thoracic duct lymphocytes from RARTS-treated donors (see Results).
Pedpheral Lymphocyte Counts.--Anlmals that underwent thoracic duct cannulation were bled preoperatively from their tail veins, and white blood counts and differential counts were pedormed. Additional adult male Lewis rats not undergoing cannulation were treated with either RARTS or NRS in the usual dose, and their white blood counts and differential counts were followed serially over the enusing 3 wk. H~stolog~al Studies.--Lymph nodes and spleens from rats sacrificed 24-48 hr after thoracic duct cannulation were sectioned and stained with hematoxylin and eosin.
RESULTS

Effect of RARTS and NRS on Peripkeral Blood Lymphocytes and Thoracic
Duct Lymphocytes.--Mter a single injection of RARTS, the numbers of small lymphocytes in the peripheral blood were depressed to approximately one fourth their normal level for about 10 days; thereafter they rapidly returned to normal (Fig. 1) . Rats receiving a single close of RARTS, whose thoracic ducts were cannulated 1-10 days later, showed an equally profound decrease in output of small lymphocytes, while rats cannulated 14--21 days after treatment drained normal numbers of cells (Fig. 1) . Neither blood nor thoracic duct small lymphocyte counts 1 were significantly affected by a single dose of NRS.
The treatment with KARTS also caused an appreciable increase in the ratio of large to small lymphocytes in both blood and thoracic duct lymph (Table I) .
NRS had a similar effect on blood lymphocytes without affecting the ratio in the thoracic duct lymph.
Kinetics of R.ARTS-Induced Suppression of Thoradc Duct Lymphocytes.--
Mter cannulation of the thoracic duct, the number of lymphocytes draining per hour remained relatively constant in untreated and NRS-treated rats (Fig. 2) . In rats receiving RARTS, however, there was a significant decrease in output beginning approximately 4 hr after treatment. During the period of maximum decline, i.e. between the 4th and 12th hr, the percentage of cells staining with trypan blue increased from a normal level of <3% to a high of approximately 18%. By 24 hr, the percentage of stained cells had returned to normal and remained so in all rats cannulated 1-21 days after treatment (see previous section). No such increase in "nonviable" (trypan blue-stained) cells occurred in the untreated or NRS treated controls.
Immunofluorescent Studies.--In rats receiving a single dose of RARTS, lymphocytes that stained with fluorescent antibody began to appear in the thoracic duct lymph 4 hr after treatment (Fig. 3) . Their percentage reached a peak (> 95) at 10-12 hr and returned to the baseline (0) at 24 hr. No staining of lymphocytes occurred after the first 24 hr or after treatment with NRS. (Table II) . In contrast, lymphocytes collected 14-21 10/0/0 from rats cannulated 1-10 days after RARTS treatment caused no detectable GVH reactions when injected in even larger doses, e.g., 40 million cells. Lymphocytes obtained from animals 14-21 days after RARTS treatment, on the other hand, possessed an almost normal capacity to initiate GVH reactions, although evidence of a slight immune incompetence remained (Table III) .
Tke Effect of Incubating Normal L ympkocytes in Cell Free Thoracic Dnct L ympk from RARTS Treated
Rats.--Since the lymphocytes from the KARTS-treated donors had been allowed to stand in a chilled mixture of lymph and Ringer's solution for 24 hr prior to injection, the possibility arose that the cells had been rendered immunologically incompetent by the in vitro exposure to the lymphRinger's mixture, rather than by the in vivo effect of the KARTS. That this was not the case, however, was shown by the experiment summarized in Table IV in which normal ceils were exposed to similar lymph-Ringer's mixtures and were found to be immunologically competent.
Histology.--Histolo~cal sections of lymph nodes and spleens from the rats which received KARTS and subsequently underwent thoracic duct cannulation (Table I) showed a pronounced depletion of small lymphocytes. Comparison with sections from the control groups (normal and NRS) revealed that the treatment with KARTS caused a generalized depletion of small lymphocytes over and above that caused by prolonged drainage of lymph from the thoracic duct.
DISCUSSION
The results of these experiments indicate that the temporary immune suppression occurring in rats treated with a single dose of KARTS is due to two effects on the small lymphocyte population: (a) a generalized depletion of small lymphocytes in the thoracic duct lymph, the blood, the spleen, and the peripheral lymph nodes, and (b) a loss of immune competence by the remaining small lymphocytes. During the first 24 hr of the depletion period, rabbit antibody can be demonstrated on a high percentage of the small lymphocytes, many of which also stain with trypan blue. From the 2nd to the 10th day, it is no longer possible to detect the changes in staining properties, but the numbers and immtmocompetence of the cells remain significantly depressed. By the 14th day, the counts and behavior of the cells have returned to normal.
The initial rapid reduction in circulating small lymphocytes that follows treatment with anti-lymphocytic serum has been frequently described (4) (5) (6) 15) although exceptions have been reported (7) . It appears to be due, at least in part, to immune lysis, which occurs in vitro and requires complement (15) . The manner in which the antiserum brings about the later phases of the response has not been defined and requires further study.
SUMMARY
Treatment of Lewis strain rats with a single subcutaneous dose of rabbit anti-rat thymocyte serum (RARTS) resulted in a marked depletion of small lymphocytes in the blood and thoracic duct lymph for approximately 10 days. While the thoracic duct lymphocytes were declining in numbers, rabbit antibody could be detected on the surfaces of a high percentage of the lymph cells. Furthermore, the thoracic duct lymphocytes were unable to initiate graft vs. host reactions during the period of depletion, even when injected in extremely large doses. Approximately 2 wk after treatment, the numbers and immune competence of the small lymphocytes returned to normal.
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